Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jbt Marel (JBTM) Cash & Equivalents (2016 - 2025)

Jbt Marel's Cash & Equivalents history spans 16 years, with the latest figure at $167.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 86.33% year-over-year to $167.9 million; the TTM value through Dec 2025 reached $167.9 million, down 86.33%, while the annual FY2025 figure was $167.9 million, 86.33% down from the prior year.
  • Cash & Equivalents reached $167.9 million in Q4 2025 per JBTM's latest filing, up from $114.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.2 billion in Q4 2024 to a low of $42.8 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $242.9 million, with a median of $106.4 million recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: soared 1008.18% in 2024, then crashed 86.33% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $78.8 million in 2021, then decreased by 9.01% to $71.7 million in 2022, then skyrocketed by 574.06% to $483.3 million in 2023, then soared by 154.17% to $1.2 billion in 2024, then plummeted by 86.33% to $167.9 million in 2025.
  • Per Business Quant, the three most recent readings for JBTM's Cash & Equivalents are $167.9 million (Q4 2025), $114.9 million (Q3 2025), and $111.8 million (Q2 2025).